AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04360473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine plus general anesthesia
Description: ketamine 0.3 mg / kg 15 minutes before balanced general anesthesia. Induction with lidocaine, fentanyl, propofol and cisatracurium. Maintenance with sevoflurane.
Study NCT04360473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate plus general anesthesia
Description: Magnesium sulfate 40 mg / kg 15 minutes before balanced general anesthesia. Induction with lidocaine, fentanyl, propofol and cisatracurium. Maintenance with sevoflurane.
Study NCT04360473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ketamine plus magnesium sulfate plus general anesthesia
Description: Ketamine 0.15 mg/kg plus magnesium sulfate 20 mg/kg 15 minutes before balanced general anesthesia. Induction with lidocaine, fentanyl, propofol and cisatracurium. Maintenance with sevoflurane
Study NCT06387446 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Valve transplant
Description: Heart valves from an organ donor will be transplanted into recipient
Study NCT06122467 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EQ Exfoliating Cleanser
Description: Product contains: Purified water, disodium laureth sulfosuccinate, coco betaine, decyl glucoside, Juglans regia (walnut) shells, PEG-40 hydrogenated castor oil, sodium cocoyl isethionate disodium cocoyl glutamate, ethoxydiglycol, xanthan gum, Root Blend Preservative (hexylene glycol, caprylyl glycol, Wasabia japonica (wasabi) root extract, Zingiber officinale (ginger) root extract, Allium sativum (garlic) bulb extract), Aloe barbadensis (aloe vera) leaf juice concentrate (Aloe barbadensis leaf juice, potassium sorbate, sodium benzoate, citric acid).
Study NCT06122467 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EQ Gel
Description: Product contains: Purified water, witch hazel (containing 14% grain alcohol), PEG-40 hydrogenated castor oil, ethoxydiglycol, xanthan gum, Root Blend Preservative (hexylene glycol, caprylyl glycol, Wasabia japonica (wasabi) root extract, Zingiber officinale (ginger) root extract, Allium sativum (garlic) bulb extract), xanthan gum.
Study NCT06122467 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EQ Moisturizer
Description: Product contains: Purified water, glycerin, dicaprylyl carbonate, cetyl alcohol, glyceryl stearate citrate, squalane, PEG-40 hydrogenated castor oil, caprylic/capric triglycerides, stearic acid, jojoba oil, phenoxyethanol SA (phenoxyethanol, caprylyl glycol, sorbic acid), ethoxydiglycol, Root Blend Preservative (hexylene glycol, caprylyl glycol, Wasabia japonica (wasabi) root extract, Zingiber officinale (ginger) root extract, Allium sativum (garlic) bulb extract), allantoin, sodium carbomer.
Study NCT06217445 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high intensity focused ultrasound
Description: High-intensity focused ultrasound (HIFU) therapy is becoming more familiar in medical field because it is non-invasive technique with fewer side effects and provides promising therapeutic results. Several HIFU therapy applications have approved by many approval authorities of deferent countries since last decade
Study NCT06217445 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Doubled chin exercises
Description: 1. Straight jaw jut. 2-ball exercise. 3-Pucker up 4. Tongue stretch 5. Neck stretch 6-bottom jaw jut.
Study NCT06187233 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: binaural music
Description: In the binaural music group, an MP3 player and in-ear stereo headphones were provided. Music therapy was applied during the procedure.
Study NCT05255445 — intervention group
Intervention type: BIOLOGICAL
Intervention: Red Blood Cell (RBC) Transfusion
Description: Simple RBC transfusion or partial manual exchange
Study NCT05637190 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Expressive Arts Therapy group intervention
Description: Art is helpful to reduce negative emotions and boost self-worth during the creative process. During the Expressive Arts Therapy workshops, participants experience different art forms, including visual art, body movement, writing, music, and guided imagery to identify the inner self and get in touch with the self to release suppressed emotions and stress.
Study NCT06114771 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: strepsilis
Description: Throat lozenge (strepsilis) was given to patients 30 minutes before the operation (the dissolution rate of the lozenge was proven to be 6-9 minutes).
Study NCT06114771 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sugar dragee in the same size and shape was given to 30 patients 30 minutes before the operation. In order not to cause any complications, sugar patients were sucked and told not to chew.
Study NCT05147337 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: E2511 matched placebo tablets.
Study NCT05186311 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Capillary Blood Collection System
Description: Test Blood Sample Collection
Study NCT05090189 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Training
Description: The present intervention will consist of a 6-month long, twice-weekly, home-based, monitored exercise training program, with training sessions lasting around 40 minutes, with 48 sessions in total. The program will be delivered in the form of 6 x 4-week blocks, which will progressively increase in intensity and complexity, as the participants physical capacities develop. Additionally, and in addition with current physical activity guidelines, participants will be instructed to perform at least an additional 70 minutes of purposeful activities per week. Study trainers will discuss the content of these activities with each individual participant to facilitate selection of suitable activities (e.g., brisk walking, jogging, stair climbing or bike riding), but their selection will be left to the discretion of the individual participants, and activity logs will be maintained throughout the study period.
Study NCT05416567 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endovascular embolization
Description: Therapeutic endovascular embolization in general anesthesia
Study NCT06427733 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo comparator
Description: SPF 30 sunscreen plus pharmaceutical formulation without green banana peel extract Control Group will use SPF 30 sunscreen plus pharmaceutical formulation without green banana peel extract
Study NCT06427733 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator
Description: SPF 30 sunscreen and pharmaceutical formulation containing green banana peel extract
Study NCT04955899 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active Stimulation
Description: The Galvani System will be implanted in eligible participants, and stimulation will be turned ON
Study NCT04386070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RESP301
Description: RESP301 is a formulation consisting of three agents already used in clinical practice: mannitol, sodium nitrite and citric acid. Delivered by a vibrating mesh nebuliser three times per day (TID) (at least 4 hours apart), for 7 days. Each dose of RESP301 is a 6ml admixture of 150mM NaNO2, 50mM mannitol and 100mM citric acid, buffered at pH 5.4.
Study NCT06485011 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Paltysma suturing
Description: platysma muscle was sutured in this group with vicryl
Study NCT04817423 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT06531304 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Lokomat Robot Assisted Gait Training
Description: Patients will underwent 12 RAGT training sessions (3 times/week for 4 consecutive weeks, 45 min each including the time for wearing the harness and the exoskeleton) with the Lokomat device as add-on to conventional regimen (5 times/week, 80 min each). The Lokomat is a technologically advanced robot-assisted gait training device. Patients are supported in a harness above a treadmill while the robotic device assists the movements of their legs to provide physiological gait. As treatment progresses, weight bearing is increased and assistance from the robotic legs is reduced, requiring the patient to gradually assume greater responsibility for movements needed during walking.
Study NCT06531304 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lokomat Robot Assisted Gait Training
Description: Patients will underwent 12 RAGT training sessions (3 times/week for 4 consecutive weeks, 45 min each including the time for wearing the harness and the exoskeleton) with the Lokomat device as add-on to conventional regimen (5 times/week, 80 min each). The Lokomat is a technologically advanced robot-assisted gait training device. Patients are supported in a harness above a treadmill while the robotic device assists the movements of their legs to provide physiological gait. As treatment progresses, weight bearing is increased and assistance from the robotic legs is reduced, requiring the patient to gradually assume greater responsibility for movements needed during walking.
Study NCT06485011 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Without Platysma suturing
Description: platysma muscle was not sutured in this group
Study NCT06524895 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medical Reiki
Description: Reiki is a form of energy therapy involving the facilitation of healing through the manipulation of biofields utilizing light touch. It is a process of targeting the energy fields around the patient's body is believed to stimulate the patient's natural ability to heal itself.
Study NCT06524895 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Reiki
Description: Sham Reiki involves a non-Reiki healer who mimics the treatment of a Reiki healer. Sham Reiki providers will be medical students who are not interested and without prior knowledge or experience with Reiki Medicine.The medical students will not have any prior experience in Reiki healing or associated energy healing modalities. It is better for this project if the medical student has no interest so there is true placebo effect being monitored.
Study NCT05805839 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C-11 ER176 Radiotracer
Description: Administered at a single time IV prior to the PET imaging. The injected dose of C-11 ER176 will be 518 MBq (14 mCi) (range 370-666 MBq; 10-18 mCi).
Study NCT05805839 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C11 Pittsburgh Compound B
Description: Administered at a single time IV prior to the PET imaging. The injected dose of C-11 PiB will be 555 MBq (range 370 - 629 MBq).
Study NCT05805839 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PET/CT scan
Description: Imaging of entire brain
Study NCT05805839 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI
Description: Magnetic Resonance Imaging of the Brain
Study NCT04817605 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic Exercise
Description: Exercise therapy based primarily in aerobic exercise according clinical guidelines last recommendations.To perform different whole body aerobic exercises with a mild to moderate intensity according to Borg scale and maximum heart rate.
Study NCT04974723 — intervention group
Intervention type: DRUG
Intervention: Abaloparatide
Description: Abaloparatide subcutaneous (abaloparatide SC \[ABL\]; Tymlos®)
Study NCT04974723 — intervention group
Intervention type: DRUG
Intervention: Teriparatide
Description: Teriparatide subcutaneous (TPTD; Forteo®)
Study NCT05399368 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RPT193
Description: RPT193 is an antagonist of the C-C motif chemokine receptor 4 (CCR4) that inhibits CCR4-mediated chemotaxis toward both CCL22 and CCL17
Study NCT05399368 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Nonactive placebo tablet
Study NCT04657601 — intervention group
Intervention type: DEVICE
Intervention: DiLumen C2 Endolumenal Interventional Platform
Description: Dual balloon accessory to an endoscope and related instruments
Study NCT05289219 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EXPOBAR
Description: Each session will start with 5 minutes of warm-up and finalization with 10 minutes of a cool-down, with work of flexibility and proprioception. The maintenance of balance and postural stability may be compromised in obese individuals, depending on the degree of obesity, although the support base provided by the position of the foot is proportional to the structural morphology of each subject. Flexibility is also gradually impaired in obese individuals and of course, these changes may be related to postural changes aggravated by a sedentary lifestyle and biological aging itself alongside all metabolic alterations inherent to the pathology of obesity (Benetti et al., 2016). And the warm-up and the cool-down will be developed as the component of training with the evolution by phases, both in time and in intensity. The first phase will include 20 minutes of interval training, encompassing circuit strength training. Each phase will have an increment of 10 minutes in the central block.
Study NCT05247008 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Thyme honey
Description: * Thyme honey will topically be applied to the oral mucosa as oral rinse based on the Biswal et al. (2003) administration protocol.~* Based on this protocol, patients will have oral rinses (20 ml of thyme honey diluted in 100 ml of purified water) 3 times per day.
Study NCT05057858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: co-formulated 300 mg TDF/ 200mg FTC
Description: Participants will be randomized into 1 of 3 groups to receive a controlled number of doses of a single tablet co-formulated 300 mg TDF/ 200mg FTC
Study NCT06319560 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine Oral Tablet
Description: 200mg daily
Study NCT06511271 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: relaxation exercises
Description: The first 10-minute part of the CD audio recordings prepared by the Turkish Psychologists Association is about deep relaxation.~purpose; The second 30-minute part includes instructions for relaxation exercises; The last 30 minutes are just consists of relaxation music
Study NCT05746767 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supported dCBT
Description: In the supported dCBT condition, each patient will receive complete access to the SilverCloud platform. In addition, patients will be assigned a supporter who will provide regular support based on an established coaching support protocol. Supporters will conduct a brief engagement call (30-40 minutes) to provide an overview of SilverCloud, identify goals, and set expectations, introduce themselves, and orient the participant to the role of the peer supporter. Supporters will then provide weekly check-ins through phone calls or messaging. Participants will be able to communicate with the supporters through the platform through messaging or sharing activities for additional discussion. The major goal of the support is to promote use of the platform.
Study NCT05746767 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Unsupported dCBT
Description: Unsupported dCBT provides all features of the SilverCloud platform with the exception of support features (structured interactions with supporter and share features). Patients will be provided complete access to SilverCloud and instructed to use it for 8-weeks. Patients will receive weekly automated messages to encourage engagement.
Study NCT05460078 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Psychiatric Transition of Care Program
Description: Behavioral Health facility or units that have discharged patients meeting inclusion criteria will be randomly assigned as either an intervention or standard care site. Intervention sites will be those using the VPTC program. This evaluation design will integrate into current workflows for the measurement of outcomes. Prior to discharge, patients may be referred to the VPTC program if they report residency or shelter in North Carolina, are 18 years of age or older on the day of discharge and can access virtual care (phone/video).~The VPTC program is defined by:~* Psychiatric consultation~* Medication management services with pharmacological consultation~* following of Health Coaching participation and provide treatment recommendations~* Tracking of behavioral health symptoms and provide treatment recommendations~* Health coaching; Psychoeducational support~* Treatment and safety planning~* Assistance connecting with an outpatient care provider
Study NCT05071313 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ad26.RSV.preF-based vaccine
Description: Ad26.RSV.preF-based vaccine will be administered as single IM injection.
Study NCT05071313 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Quadrivalent High-dose Influenza Vaccine
Description: Quadrivalent High-dose Influenza Vaccine will be administered as IM injection.
Study NCT05071313 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered as IM injection to Ad26.RSV.preF-based vaccine.
Study NCT06544681 — intervention group
Intervention type: PROCEDURE
Intervention: Coronary stenting with planned drug eluting stent (DES).
Description: Stenting will be performed with OCT guidance according to the algorithm described in the protocol. A deep learning-based OCT system was used to measure the adherence of coronary stents.
Study NCT04444843 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Mycophenolate Mofetil Capsules
Description: Patients who received MMF+TAC+ Corticosteroids immunosuppressive regimen as first choice post transplantation
Study NCT04695704 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Montelukast
Description: 10 mg oral montelukast once daily for 28 days
Study NCT04695704 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 10 mg oral placebo once daily for 28 days
Study NCT05701241 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Somatostatin analog
Description: Somatostatin analog treatment every 4 weeks
Study NCT04692467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine 5mg
Description: Amlodipine, Haiti's first-line antihypertensive medication, will be administered to the intervention group.
Study NCT05716022 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood Collection
Description: Prior to subject's surgical procedure, blood (about 3 tablespoons (44 mL)) will be collected through a needle in vein for research purposes. The UVA researchers will analyze the biomarkers that are expressed in subject's blood.
Study NCT05716022 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Bronchoscopy
Description: Following blood collection, the subject will undergo the bronchoscopy for research purposes. While in the operating room, a bronchoscope will be inserted through the breathing tube that is already been placed for the surgery. Subject's airways will be examined with the bronchoscope in both lungs. Ten tablespoons (150 mL) of saline solution will be injected into one of subject airways. The fluid will be re-collected by suctioning it back up with the bronchoscope. The fluid will be collected from the bronchscope.
Study NCT05196971 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10345 84mg
Description: 6 sprays of HS-10345 84 mg self-administered as an intranasal formulation for 4 days (Days 1, 4, 8, 11) during the double-blind phase
Study NCT05196971 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 6 sprays of placebo self-administered as an intranasal formulation for 4 days (Days 1, 4, 8, 11) during the double-blind phase
Study NCT06141720 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: pain education
Description: Pain education
Study NCT06141720 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mindfulness of pain introduction and intervention
Description: Brief mindfulness of pain introduction and intervention
Study NCT06062524 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aorta Vascular Plug System
Description: The Aorta Vascular Plug System for false lumen is composed of a vascular plug system and an adjustable bend conveyor. The plug system is composed of a patch and a conveying steel cable. The plug is pre-installed on the conveying steel cable.
Study NCT04855045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sepofarsen
Description: RNA antisense oligonucleotide for intravitreal injection
Study NCT05411601 — intervention group
Intervention type: OTHER
Intervention: Methodology of attachment of external foot prothesis
Description: establishing the methodology of specific measurements of attachment of external foot prothesis
Study NCT05308849 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Dosage of serum and peritoneal of the betalactam used for antibiotic treatment
Description: All patients will have antibiotherapy according to French recommendation.~Antibiotics recommended are:~cefotaxime 200mg/kg/d / OR amoxicillin/clavulanic acid 25 mg/kg x 3 /d OR piperacilline/tazobactam 100 mg/kg/d~Blood samples will be collected before surgery and after surgery (for all patients).~Peritoneal sample will be collected during surgery (for all patients). Additionnal optionnal blood sample could be collected on Day 5 after surgery. Additionnal optionnal peritoneal samples could be collected on Day 2 and Day 5.~Dosage of serum and peritoneal of the used betalactam will be performed by High Performance Liquid Chromatography Method
Study NCT05732077 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Dopamine
Description: A bolus dose of 50μg/kg dopamine via renal artery to induce hyperemic status
Study NCT05732077 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Fractional Flow Reserve, Renal
Description: Renal FFR will be measured based on SOP
Study NCT05732077 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Renal artery stenting
Description: Renal artery stenting will be implanted based on the protocol